Question:
Do you know whether CMS has announced any new pass-through codes for the next quarter?
Answer:
Yes, effective July 1, 2017, the two codes below will assume pass-through status:
C9489 | Injection, nusinersen, 0.1 mg |
C9490 | Injection, bezlotoxumab, 10 mg |